DNA lesion-recognizing proteins and the p53 connection

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 225-242

  Boulikas, Teni ^a  

^a Inst of Molecular Medical Sciences   (United States)

Author keywords

AP endonuclease; Cisplatin; DNA glycosylase; Drug resistance; HMG box; HMG1; Mismatch repair; Nuclear matrix; Nucleotide excision repair; Xeroderma pigmentosum

Indexed keywords

CISPLATIN; DNA GLYCOSYLTRANSFERASE; GENE PRODUCT; HIGH MOBILITY GROUP PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR;

BINDING AFFINITY; CELL CYCLE; COLON CANCER; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; EXCISION REPAIR; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; XERODERMA PIGMENTOSUM;

ANIMALS; DNA DAMAGE; DNA LIGASES; DNA REPAIR; HIGH MOBILITY GROUP PROTEINS; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029919301     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (187)

1. Hanawalt PC: DNA repair comes of age. Mutat Res 336: 101-113, 1995.
2. Boulikas T: Evolutionary consequences of preferential damage and repair of chromatin domains. J Mol Evol 35: 156-180, 1992.
3. Cleaver JE: It was a very good year for DNA repair. Cell 76: 1-4, 1994.
4. Abousekhra A, Biggerstaff M, Shivji MKK, Vilpo JA, Moncollin V, Podust VN, Protic M, Hübsher U, Egly J-M, and Wood RD: Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell 80: 859-868, 1995.
5. Lommel L and Hanawalt PC: Increased UV resistance of a xeioderma pigmentosum revenant cell line is correlated with selective repair of the transcribed strand of an expressed gene. Mol Cell Biol 13: 970-976, 1993.
6. Islas AL and Hanawalt PC: DNA repair m the MYC and FMK protooncogenes in ultraviolet light-irradiated human HL60 promyelocytic cells during differentiation. Cancer Res 55: 336-341, 1995.
7. Hanawalt PC: Transcription-coupled repair and human disease. Science 266: 1957-1958, 1994.
8. Coverley D, Kenny MK, Lane DP, and Wood RD: A role for the human single-stranded DNA binding protein HSSB/RPA in an early stage of nucleotide excision repair. Nucleic Acids Res 20: 3873-3880, 1992.
9. Emery HS, Schild D, Kellogg DE, and Mortimer RK: Sequence of RAD54, a Saccharomyces cerevisiae gene involved in recombination and repair. Gene 104: 103-106, 1991.
10. 2 checkpoint pathways in Schizosaccharomyces pombe. EMBO J 11: 1343-1350, 1992.
11. Rowley R, Subramani S and Young PG: Checkpoint controls in Schizosaccharomyces pombe: tad1. EMBO J 11: 1335-1342, 1992.
12. Hoeijmakers JHJ and Bootsma D: Molecular genetics of eukaryotic DNA excision repair. Cancer Cells 2: 311-320, 1990.
13. Wood RD and Coverley D: DNA excision repair in mammalian cell extracts. BioEssays 13: 447-453, 1991.
14. Tanaka K, Miura N, Satokata I, Miyamoto I, Yoshida MC, Satoh Y, Kondo S, Yasui A, Okayama H and Okada Y: Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain. Nature 343: 73-76, 1990.
15. Weeda G, van Ham RCA, Vermeulen W, Bootsma D, van der Eb AJ and Hoeijmakers JHJ. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell 62: 777-791, 1990.
16. Weber CA, Salazar EP, Stewart SA and Thompson LH: ERCC-2-cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast Rad3. EMBO J 9: 1437-1447, 1990.
17. Schaeffer L, Roy R, Humbert S, Moncolllin V, Vermeulen W, Hoeijmakers JHJ, Chambon P and Egly J-M: DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 260: 58-63, 1993
18. Feaver WJ, Svejstrup JQ, Bardwell L, Bardwell AJ, Buratowski S, Gulyas KD, Donahue TF, Friedberg EC and Kornberg RD: Dual roles of a multiprotein complex from S. cerevisiae in transcription and DNA repair. Cell 75 1379-1387, 1993.
19. Qui H, Park E, Prakash L and Prakash S: The Saccharomyces cerevisiae DNA repair gene RAD25 is required for transcription by RNA polymerase II. Genes Dev 7: 2161-2171, 1993.
20. Bohr VA, Smith CA, Okumoto DS and Hanawalt PC: DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 40: 359-369, 1985.
21. Mellon I, Spivak G and Hanawalt PC: Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51: 241-249, 1987.
22. Pu WT, Kahn R, Munn M and Rupp WD: Uvr ABC incision of N-methylmitomycin A-DNA monoadducts and cross-links. J Biol Chem 264: 20697-20704, 1989.
23. van Houten B: Nucleotide excision repair in Escherichia coli. Microbiol Rev 54: 18-51, 1990.
24. Robins P, Jones CJ, Biggerstaff M, Lindahl T and Wood RD: Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA. EMBO J 10: 3913-3921, 1991.
25. Chu G and Chang E: Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 242: 564-567, 1988.
26. Chu G and Chang E: Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proc Natl Acad Sci USA 87: 3324-3327, 1990.
27. Kantor GJ, Barsalou LS and Hanawalt PC: Selective repair of specific chromatin domains in UV-irradiated cells from xeroderma pigmentosum complementation group C. Mutat Res 235: 171-180, 1990.
28. Christians FC and Hanawalt PC: Repair in ribosomal RNA genes is deficient in xeroderma pigmentosum group C and in Cockayne's syndrome cells Mutat Res 323: 179-187, 1994.
29. Jones CJ and Wood RD: Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA Biochemistry 32: 12096-12104, 1993.
30. Oh EY and Grossman L: Helicase properties of the Escherichia coli UvrAB protein complex. Proc. Natl. Acad. Sci. USA 84: 3638-3642, 1987.
31. Bankmann M, Prakash L and Prakash S: Yeast RAD14 and human xeroderma pigmentosum group A DNA-repair genes encode homologous proteins. Nature 355: 555-558, 1992.
32. Guzder SN, Sung P, Prakash L and Prakash S: Yeast DNA-repair gene RAD14 encodes a zinc metalloprotein with affinity for ultraviolet-damaged DNA. Proc Natl Acad Sci USA 90 5433-5437, 1993.
33. Kataoka H and Fujiwara Y: UV damage-specific DNA-binding protein in xeroderma pigmentosum complementation group E. Biochem Biophys Res Comm 175: 1139-1143, 1991.
34. Keeney S, Wem H and Linn S: Biochemical heterogeneity in xeroderma pigmentosum complementation group E. Mutat Res 273: 49-56, 1992.
35. Abramic M, Levine AS and Protic M: Purification of an ultraviolet-inducible, damage-specific DNA-binding protein from primate cells. J Biol Chem 266: 22493-22500, 1991.
36. van Assendelft GB, Rigney EM and Hickson ID: Purification of a HeLa cell nuclear protein that binds selectively to DNA irradiated with ultraviolet light Nucleic Acids Res 21: 3399-3404, 1993.
37. van Hoffen A, Venema J, Meschini R, van Zeeland AA and Mullenders LHF: Transcription-coupled repair removes both cyclobutane pyrimidine dimers and 6-4 photoproducts with equal efficiency and in a sequential way from transcribed DNA in xeroderma pigmentosum group C fibroblasts. EMBO J 14: 360-367, 1995.
38. Venema J, van Hoffen A, Karcagi V, Natarajan AT, van Zeeland AA and Mullenders LHF: Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol Cell Biol 11: 4128-4134, 1991.
39. Legerski R and Peterson C: Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C. Nature 359: 70-73, 1992.
40. Boulikas T: Chromatin and nuclear matrix in development and in carcinogenesis: a theory. Int J Oncol 1: 357-372, 1992.
41. Boulikas. T: Chromatin domains and prediction of MAR sequences. Int Rev Cytol: 162A: 279-388, 1995
42. Masutani C, Sugasawa K, Yanagisawa J, Sonoyama T, Ui M, Enomoto T, Takio K, Tanaka K, van der Spek PJ, Bootsma D, Hoeijmakers JHJ and Hanaoka F: Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J 13: 1831-1843, 1994.
43. Treiber DK, Chen Z and Essigmann JM: An ultraviolet light-damaged DNA recognition protein absent in xeroderma pigmentosum group E cells binds selectively to pyrimidine (6-4) pyrimidone photoproducts. Nucleic Acids Res 20: 5805-5810, 1992.
44. Hasegawa SL, Doetsch PW, Hamilton KK, Martin AM, Okenquist SA, Lenz J and Boss JM: DNA binding properties of YB-1 and dbpA: binding to double-stranded, single-stranded, and abasic site containing DNAs. Nucleic Acids Res 19: 4915-4920, 1991.
45. Patterson M and Chu G: Evidence that xeroderma pigmentosum cells from complementation group E are deficient in a homolog of yeast photolyase. Mol Cell Biol 9: 5105-5112, 1989.
46. 6-ethenoadenine in a DNA fragment. Proc Natl Acad Sci USA 88: 6839-6842, 1991.
47. Oliver T and Mead G: Testicular cancer. Curr Opin Oncol 5. 559-567, 1993.
48. Bruhn SL, Pil PM, Essigman JM, Housman DE and Lippard SJ: Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc Natl Acad Sci USA 89. 2307-2311, 1992.
49. Bellon SF, Coleman JH and Lippard SJ: DNA Unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diammmedichloroplatinum(II). Biochemistry 30: 8026-8035, 1991.
50. Pil PM and Lippard SJ: Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 256: 234-237, 1992.
51. Buchanan RL and Gralla JD: Cisplatin resistance and mechanism in a viral test system: SV40 isolates that resist inhibition by the antitumor drug have lost regulatory DNA. Biochemistry 29: 3436-3442, 1990.
52. Mymryk JS, Zaniewski E and Archer TK: Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo. Proc Natl Acad Sci USA 92: 2076-2080, 1995.
53. Chao CC-K, Huang S-L, Lee L-Y and Lin-Chao S: Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamimnedichloroplatinum(II). Biochemistry J 277: 875-878, 1991.
54. Toney JH, Donahue BA, Kellett PJ, Bruhn SL, Essigmann JM and Lippard SJ: Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II). Proc Natl Acad Sci USA 86: 8328-8332, 1989.
55. Donahue BA, Augot M, Bellon SF, Treiber DK, Toney JH, Lippard SJ and Essigmaim JM: Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin. Biochemistry 29 5872-5880, 1990.
56. Hughes EN, Engelsberg BN and Billings PC: Purification of nuclear proteins that bind to cisplatin-damaged DNA. J Biol Chem 207: 13520-13527, 1992.
57. Brown SJ, Kellett PJ and Lippard SJ: lxr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin Science 261: 603-605, 1993.
58. Shirakata M, Hüppi K, Usuda S, Okazaki K, Yoshida K and Sakano H HMG1-related DNA-binding protein isolated with V-(D)-J recombination signal probes. Mol Cell Biol 11: 4528-4536, 1991.
59. Teo S-H, Grasser KD, Hardman CH, Broadhurst RW, Laue ED, and Thomas JO: Two mutations in the HMG-box with very different structural consequences provide insights into the nature of binding to four-way junction DNA. EMBO J 14: 3844-3853.
60. Boulikas T: A compilation and classification of DNA binding sites for protein transcription factors from vertebrates. Crit Rev Eukar Gene Expr 4: 117-321.
61. Gros P, Croop J and Housman D: Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380, 1986.
62. Chen C-J, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM and Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381-389, 1986.
63. Richon VM, Schulte N and Eastman A: Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells. Cancer Res 47: 2056-2061, 1987.
64. Scanlon KJ and Kashani-Sabet M. Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells Proc Natl Acad Sci USA 85: 650-653, 1988.
65. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH and Lazo JS: Overexpression of metallothionein confers resistance to anticancer drugs. Science 241: 1813-1815, 1988.
66. Boulikas T: Homeodomain protein binding sites, inverted repeats, and nuclear matrix attachment regions along the human β-globin gene complex. J Cell Biochem 52: 23-36, 1993.
67. Pearson CE, Zannis-Hadjopoulos M, Price GB and Zorbas H: A novel type of integration between cruciform DNA and a cruciform-binding protein from HeLa cells. EMBO J 14:1571-1580, 1995.
68. Vilpo JA, Vilpo LM, Szymkowski DE, O'Donovan A and Wood RD: An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells. Mol Cell Biol 15: 290-297, 1995.
69. Habraken Y, Sung P, Prakash L and Prakash S. Yeast excision repair gene RAD2 encodes a single-stranded DNA endonuclease. Nature 366: 365-368, 1993.
70. Tomkinson AE, Bardwell AJ, Bardwell L, Tappe NJ and Friedberg EC: Yeast DNA repair and recombination proteins Rad1 and Rad10 constitute a single-stranded-DNA endonuclease. Nature 362: 860-862, 1993.
71. Sung P, Reynolds P, Prakash L and Prakash S: Purification and characterization of the Saccharomyces cerevisiae RAD1/RAD10 endonuclease. J Biol Chem 268: 26391-26399, 1993.
72. + tumor cells. Cell 75: 1227-1236, 1993
73. Modrich P: Mechanisms and biological effects of mismatch repair. Annu Rev Genet 25: 229-253, 1991.
74. Jiricny J, Hughes M, Corman N and Rudkin BB: A human 200-kDa protein binds selectively to DNA fragments containing G T mismatches Proc Natl Acad Sci USA 85: 8860-8864, 1988.
75. Stephenson C and Karran P: Selective binding to DNA base pair mismatches by proteins from human cells. J Biol Chem 264: 21177-21182, 1989.
76. Branch P, Aquilina Q, Bignami M and Karran P: Defective mismatch binding and a imitator phenotype in cells tolerant to DNA damage. Nature 362: 652-654, 1993.
77. + gene of Schizosaccharomyces pombe encodes a homologue of mismatch repair enzymes. Nucleic Acids Res 20: 2271-2278, 1992.
78. Fujii H and Shimada T: Isolation and characterization of cDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase gene. J Biol Chem 264: 10057-10064, 1989.
79. Linton JP, Yen J-YJ, Selby E, Chen Z, Chinski JM, Liu K, Kellems RE and Grouse GF: Dual bidirectional promoters at the mouse dhfr locus: cloning and characterization of two mRNA classes of the divergently transcribed Rep-1 gene. Mol Cell Biol 9: 3058-3072, 1989.
80. Su S-S, Lahue RS, Au KG and Modrich P: Mispair specificity of methyl-directed DNA mismatch correction in vitro. J Biol Chem 263: 6829-6835, 1988.
81. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, and Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpotyposis colon cancer. Cell 75: 1027-1038, 1993.
82. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen A, Nystom-Lahti M, Guan X-Y, Zhang J, Meltzer PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Jarvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chepelle A, Kinzler KW and Vogelstein B: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225, 1993.
83. Weinert TA and Hartwell LH: The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241: 317-322, 1988.
84. Friedberg EC: Yeast genes involved in DNA-repair processes: new looks on old faces Molec Microbiology 5: 2303-2310, 1991.
85. Carr AM and Hoekstra MF: The cellular response to DNA damage. Trends Cell Biol 5: 32-40, 1995.
86. Couto LB and Friedberg EC: Nucleotide sequence of the wild-type RAD4 gene of Saccharomyces cerevisiae and characterization of mutant rad4 alleles. J Bacteriol 171: 1862-1869, 1989.
87. Karran P and Bignami M: Self-destruction and tolerance in resistance of mammalian cells to alleviation damage. Nucleic Acids Res 20: 2933-2940, 1992.
88. 6- methylguanine-DNA transmethylase from rat liver. J Biol Chem 258: 2327-2333, 1983.
89. Dolan ME, Oplinger M and Pegg AE: Sequence specificity of guanine alkylation and repair. Carcinogenesis 9: 2139-2143, 1988.
90. Oesch F, Aulmann W, Platt KL and Doerjer G: Individual differences in DNA repair capacities in man Arch Toxicol Suppl 10: 172-179, 1987.
91. 6-alkyiguanine-DNA-alkyltransferase based on the use of an oligonucleotide substrate, and its application to the measurement of DNA repair activity in extracts of biopsy samples of human urinary bladder mucosa. Carcinogenesis 10: 1203-1208, 1989.
92. Montesano R: Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis. J Supramol Struct Cell Biochem 17: 259-273, 1981.
93. 6-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis Mutat Res 145: 1-16, 1985.
94. 6-methylguanine in rat pulmonary cells. Carcinogenesis 9: 2053-2058, 1988.
95. 6-alkylguanine-DNA alkyltransferase. Cancer Res 44: 3806-3811, 1984.
96. 6-methylguanine. J Biol Chem 267: 9879-9885, 1986.
97. 6-methylguanine residues when present in Z-DNA. J Biol Chem 260: 8711-8715, 1985.
98. Sancar A: Structure and function of DNA photolyase. Biochemistry 33. 2-9, 1994.
99. Teo I, Sedgwick B, Demple B, Li B and Lindahl T: Induction of resistance to alkylating agents in E. coli: the ada+ gene product serves both as a regulatory protein and as an enzyme for repair of mutagenic damage. EMBO J 3: 2151-2157, 1984
100. Sakumi K and Sekiguchi M: Structures and functions of DNA giycosylases. Mutat Res 236: 161-172, 1990..
101. Wiebauer K and Jirieny J: Mismatch-specific thymine DNA glycosylase and DNA polymeraseß mediate the correction of G:T mispairs in nuclear extracts from human cells. Proc Natl Acad Sci USA 87: 5842-5845, 1990.
102. Au KG, Clarck S, Miller JH and Modrich P: Escherichia coli mut Y gene encodes an adenine glycosylase active on G:A mispairs. Proc Natl Acad Sci USA 86: 8877-8881, 1989.
103. Helland DE, Male R, Haukanes BI, Olsen L, Haugan I and Kleppe K: Properties and mechanism of action of eukaryotic 3-methyladenine-DNA glycosylases. J Cell Sci Suppl 6: 139-146, 1987.
104. Berdal KG, Bjørdås M, Bjelland S and Seeberg E: Cloning and expression in Escherichia coli of a gene for an alkylbase DNA glycosylase from Saccharomyces cerevisiae; a homologue to the bacterial alkA gene. EMBO J 3: 4563-4568, 1990
105. Lindahl T: Instability and decay of the primary structure of DNA. Nature 362: 709-715, 1993.
106. Shen J-C, Rideout III WM and Jones PA: High frequency mutagenesis by a DNA methyltransferase. Cell 71: 1073-1080, 1992.
107. Duncan BK and Weiss B: Specific mutator effects of ung (Uracil-DNA glycosylase) mutations in Escherichia coli. J Bacteriol 151: 750-755, 1982.
108. Mol CD, Arvai AS, Slupphaug G, Kavli B, Alseth I, Krokan HE and Tainer JA: Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell 80: 869-878, 1995.
109. Olsen LC, Aasland R, Wittwer CU, Krokan HE and Helland DE: Molecular cloning of human uracil-DNA glycosylase, a highly conserved DNA repair enzyme. EMBO J 8: 3121-3125, 1989.
110. Haug T, Skorpen F, Lund H and Krokan HE: Structure of the gene for human uracil-DNA glycosylase and analysis of the promoter function. FEBS Lett 353: 180-184, 1994.
111. Wiebauer K and Jiricny J: In vitro correction of G:T mispairs to G:C pairs in nuclear extracts from human cells. Nature 339: 234-236, 1989.
112. Frederico LA, Kunkel TA and Shaw BR: A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy. Biochemistry 29: 2532-2537, 1990.
113. Dianov G and Lindahl T: Preferential recognition of I:T base-pairs in the initiation of excision-repair by hypoxanthine-DNA glycosylase. Nucleic Acids Res 19: 3829-3833, 1991.
114. Brown TC and Jiricny J: Different base/base mispairs are corrected with different efficiencies and specificities in monkey kidney cells. Cell 54: 705-711, 1988.
115. Cedar H. DNA methylation and gene activity. Cell 53: 3-4, 1988.
116. Livneh Z, Elad D and Sperling J: Enzymatic insertion of purine bases into depurinated DNA in vitro . Proc Natl Acad Sci USA 76: 1089-1093, 1979.
117. Lindahl T: DNA repair enzymes. Annu Rev Biochem 51: 61-87, 1982
118. Doetsch PW and Cunningham RP: The enzymology of apurinic/apyrimidinic endonucleases Mutat Res 236 173-201, 1990.
119. Kane CM and Linn S: Purification and characterization of an apurinic/apyrimidinic endonuclease from HeLa cells. J Biol Chem 256: 3405-3414, 1981.
120. Robson CN, Milne AM, Pappin DJC and Hickson: Isolation of cDNA clones encoding an enzyme from bovine cells that repairs oxidative DNA damage in vitro: Homology with bacterial repair enzymes. Nucleic Acids Res 19: 1087-1092, 1991.
121. Demple B, Herman T and Chen DS. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc Natl Acad Sci USA 88: 11450-11454, 1991.
122. Sander M, Lowenhaupt K, Lane WS and Rich A: Cloning and characterization of Rrp1, the gene encoding Drosophila strand transferase: carboxy-terminal homology to DNA repair endo/exonucleases. Nucleic Acids Res 19: 4523-4529, 1991.
123. Xanthoudakis S, Miao G, Wang F, Pan Y-CE and Curran T: Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 11. 3323-3335, 1992.
124. Kumar S, Rabson AB and Gélinas C: The RxxRxRxxC motif conserved in all Rel/kB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol Cell Biol 12: 3094-3106. 1992.
125. Matthews JR, Wakasugi N, Virelizier J-L, Yodoi J and Hay RT: Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20: 3821-3830, 1992.
126. Walker O, Robson CN, Black E, Gillespie D and Hickson ID: Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding. Mol Cell Biol 13. 5370-5376, 1993.
127. Watson JD and Crick FHC: The structure of DNA Cold Spring Harbor Symp Quant Biol 18. 123-131, 1953.
128. Echols H and Goodman MF: Fidelity mechanisms in DNA replication. Ann Rev Biochem 60: 477-511, 1991.
129. Loeb LA and Kunkel TA: Fidelity of DNA synthesis. Annu Rev Biochem 51. 429-457, 1982.
130. Modrich P: DNA mismatch correction. Ann Rev Biochem 56: 435-466, 1987.
131. Alberts B, Bray D, Lewis J, Raff M, Roberts K and Watson JD (1983). In "Molecular Biology of the Cell," pp. 1-1146. Garland. New York.
132. Rathmell WK and Chu G: A DNA end-binding factor involved in double-strand break repair and V(D)J recombination. Mol Cell Biol 14: 4741-4748, 1994.
133. Taccioli GE, Gottlieb TM, Blunt T, Priestley A, Demengeot J, Mizuta R, Lehmann AR, Alt FW, Jackson SP and Jeggo PA: Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 265: 1442-1445, 1994.
134. Boulikas T: Poly(ADP-ribosyl)ation, DNA strand breaks, chromatin and cancer. Toxicol Lett 67: 129-150, 1993.
135. Farzaneh F, Panayotou GN, Bowler LD, Hardas BD, Broom T, Walther C and Shall S: ADP-ribosylation is involved in the integration of foreign DNA into the mammalian cell genome. Nucleic Acids Res 16: 11319-11326, 1988.
136. Küpper J-H, Müller M, Jacobson MK, Tatsumi-Miyajima J, Coyle DL, Jacobson EL and Burkle A: trans-Dominant inhibition of poly(ADP-ribosyl)ation sensitizes cells against γ-irradiation and N-Methyl-N′-Nitro-N-Nitrosoguanidine but does not limit DNA replication of a polyomavirus replicon. Mol Cell Biol 15: 3154-3163, 1995
137. Wang Z-Q, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M and Wagner: Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 9. 509-520, 1995.
138. Taccioli GE, Rathbun G, Oltz E, Stamato T, Jeggo PA and Alt FW. Impairment of V(D)J recombination in double-strand break repair mutants Science 260 207-210, 1993.
139. Lieber MR, Hesse JE, Lewis S, Bosma GC, Rosenberg N, Mizuuchi K, Bosma MJ and Gellert M. The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell 55: 7-16, 1988.
140. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495, 1992
141. Lee S, Elenbaas B, Levine A and Griffith J: p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 51: 1013-1020, 1995.
142. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Nordenskjeld M, Fishel R, Kolodner R and Liskay RM: Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258-261, 1994.
143. Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomaki P, Mecklin J-P, de la Chapelle A, Kinzler KW and Vogelstein B: Mutation of a mutL homolog in hereditary colon cancer. Science 263: 1625-1629, 1994.
144. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B: and Kanzler KW: Mutations of two PMS homologues, in hereditary nonpolyposis colon cancer. Nature 377: 75-80, 1994.
145. Boulikas T and Kong CF: A novel class of matrix attached regions (MARs) identified by random cloning and their implications in differentiation and carcinogenesis. Int J Oncol 2: 325-330, 1993.
146. Boulikas T: Common structural features in origins of replication among all life forms J Cell Biochem, in press, 1996.
147. Dutta A, Ruppert JM, Aster JC and Winchester E: Inhibition of DNA replication factor RPA by p53. Nature 365: 79-82. 1993.
148. Li R and Botchan MR: The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stumulate in vitro BPV-1 DNA replication. Cell 73: 1207-1221, 1993.
149. Xiao H, Pearson A, Coulombe B, Truant R, Zhang S, Regier JL, Triezenberg SJ, Reinberg D, Flores O, Ingles CJ and Greenblatt J: Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol 14: 7013-7024, 1994.
150. Wang Z, Svejstrup JQ, Feaver WJ, Wu X, Kornberg RD and Friedberg EC: Transcription factor b (TFIIH) is required during nucleotide excision repair in yeast. Nature 368: 74-76, 1994.
151. Deppert W: The yin and yang of p53 in cellular proliferation. Semin Cancer Biol 5. 187-202, 1994.
152. Lin J, Chen J, Elenbaas B and Levine AJ: Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kd protein. Genes Dev 8: 1235-1246, 1994.
153. Wang Y, Reed M, Wang P, Stenger JE, Mayr G, Anderson ME, Schwedes JF and Tegtmeyer P: p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev 7: 2575-2586, 1993.
154. Pavletich NP, Chambers KA and Pabo CO: The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 7: 2556-2564, 1993
155. Bargonetti J, Manfredi JJ. Chen X, Marshak DR and Prives C: A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev 7: 2565-2574, 1993.
156. Wu L, Bayle JH, Elenbaas B, Pavletich NP and Levine AJ: Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids. Mol Cell Biol 15: 497-504, 1995.
157. Jayaraman L and Prives C: Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81: 1021-1029, 1995.
158. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular reponse to DNA damage. Cancer Res 51. 6304-6311, 1991.
159. Nelson WG and Kastan MB: DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14: 1815-1823, 1994
160. Price BD and Calderwood SK: Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene 8: 3055-3062, 1993.
161. Tishler RB, Calderwood SK, Coleman CN and Price BD: Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res 53: 2212-2216, 1993.
162. Chowdary DR, Dermody JJ, Jha KK and Ozer UL: Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol Cell Biol 14: 1997-2003, 1994.
163. Jentsch S, McGrath JP and Varshavsky A: The yeast DNA repair gene RADd encodes a ubiquitin-conjugating enzyme. Nature 329: 131-134, 1987.
164. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression Cell 75: 817-825, 1993.
165. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangieclasia. Cell 71: 587-597, 1992.
166. Okamoto K and Beach D: Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 13: 4816-4822, 1994.
167. Perry ME, Piette J, Zawadzki JA, Harvey D and Levine AJ: The mdm-2 gene is induced in response to UV light in a p53-dependent manner Proc Natl Acad Sci USA 90: 11623-11627, 1993.
168. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B and Costa J: Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89: 4495-4499, 1992
169. Wu X and Levine AJ: p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91: 3602-3606, 1994.
170. Smith ML, Chen I-T, Zhan O, Bae I, Chen C-Y, Gilmer TM, Kastan MB, O'Connor PM and Fornace AJ: Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen Science 266: 1376-1380, 1994.
171. Lu X and Lane DP: Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75: 765-778, 1993.
172. Bakalkin G, Selivanova G, Yakovleva T, Kiseleva E, Kashuba E, Magnusson KP, Szekely L, Klein G, Terenius L and Wiman KG: p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucleic Acids Res 23: 362-369, 1995.
173. Cleaver JE: Defective repair replication of DNA in Xeroderma pigmentosum. Nature 218: 652-656, 1968
174. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin J-P, Jarvinen H, Powell SM, Jen J, Hamilton SR, Peterson GM, Kinzler KW, Vogelstein B and de la Chapelle A: Clues to the pathogenesis of familial colorectal cancer. Science 260. 812-816, 1993.
175. Martin JB: Molecular genetics of neurological diseases. Science 262: 674-676, 1993
176. Spandidos DA: Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors. Anticancer Res 5: 485-498, 1985.
177. Martin GS, Brugge J, Darnell JE, Verma IM, Klein G, Stanbridge E, Wang J, Cory S, Rowley JD and Berg P: Oncogenes: 20 years later Genes Dev 9: 1289-1301, 1995.
178. Bouhkas T: Phosphorylation of transcription factors and control of the cell cycle. Crit Rev Eukaryotic Gene Expr 5: 1-77, 1995.
179. Takao M, Abramic M, Moos M, Otrin VR, Wootton JC, McLenigan M, Levine AS and Protic M: A 127 kDa component of a UV-damaged DNA-binding complex, which is defective in some xeroderma pigmentosum group E patients, is homologous to a slime mold protein. Nucleic Acids Res 21. 4111-4118, 1993.
180. Clugston CK, McLaughhn K, Kenny MK and Brown R: Binding of human single-stranded DNA binding protein to DNA damaged by the anticancer drug cis-diamminedichloroplatinum (II). Cancer Res 52: 6375-6379, 1992.
181. Lenz J, Okenquist SA, LoSardo JE, Hamilton KK and Doetsch PW: Identification of a mammalian nuclear factor and human cDNA-encoded proteins that recognize DNA containing apurinic sites. Proc Natl Acad Sci USA 87: 3396-3400, 1990.
182. Moranelli F and Lieberman MW: Recognition of chemical carcinogen-modified DNA by a DNA-binding protein. Proc Natl Acad Sci USA 77: 3201-3205, 1980.
183. Evans MK, Taffe BG, Harris CC, and Bohr VA: DNA strand bias in the repair of the p53 gene in normal and xeroderma pigmentosum group C fibroblasts. Cancer Res 53: 5377-5381, 1993.
184. Ford JM, Lommel L and Hanawalt PC: Preferential repair of ultraviolet light-induced DNA damage in the transcribed strand of the human pS3 gene. Molec Carcin 10: 105-109, 1994.
185. Rady P, Scinicariello F, Wagner RF, and Tyring SK: p53 mutations in basal cell carcinomas. Cancer Res 82: 3804-3806, 1992.
186. Dumaz, N, Drougard C, Sarasin A, and Daya-Grosjean L: Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 90: 10529-10533, 1993.
187. Boulikas T: Xeroderma pigmentosum and molecular cloning of DNA repair genes. Anticancer Res 16: 1996, in press.